Paul Steven M's Form 4 filing
Alnylam Pharmaceuticals, Inc. (ALNY) · filed Apr 5, 2022
- Accession no.
- 0001735276-22-000039
- Filed
- Apr 5, 2022
- Trade date
- Apr 1, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 11 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.56M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Paul Steven MCIK 0001237564 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2022 | Common Stock | MOption exerciseAcquired | +15,000 | $11.33 | +$169,950 | 16,000 | Direct | |
| Apr 1, 2022 | Common Stock | SSaleDisposed | −253 | $166.04F2 | −$42,008.12 | 15,747 | Direct | |
| Apr 1, 2022 | Common Stock | SSaleDisposed | −4,948 | $168.95F3 | −$835,964.6 | 10,799 | Direct | |
| Apr 1, 2022 | Common Stock | SSaleDisposed | −4,872 | $169.71F4 | −$826,827.12 | 5,927 | Direct | |
| Apr 1, 2022 | Common Stock | SSaleDisposed | −1,235 | $171.16F5 | −$211,382.6 | 4,692 | Direct | |
| Apr 1, 2022 | Common Stock | SSaleDisposed | −1,434 | $172.10F6 | −$246,791.4 | 3,258 | Direct | |
| Apr 1, 2022 | Common Stock | SSaleDisposed | −642 | $173.06F7 | −$111,104.52 | 2,616 | Direct | |
| Apr 1, 2022 | Common Stock | SSaleDisposed | −90 | $174.33 | −$15,689.7 | 2,526 | Direct | |
| Apr 1, 2022 | Common Stock | SSaleDisposed | −526 | $176.51F8 | −$92,844.26 | 2,000 | Direct | |
| Apr 1, 2022 | Common Stock | SSaleDisposed | −825 | $177.58F9 | −$146,503.5 | 1,175 | Direct | |
| Apr 1, 2022 | Common Stock | SSaleDisposed | −175 | $178.60 | −$31,255 | 1,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2022 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Sale prices ranged from $165.91 to $166.41.
Referenced by the price of 1 transaction in Table I.
- F3
Sale prices ranged from $168.30 to $169.30.
Referenced by the price of 1 transaction in Table I.
- F4
Sale prices ranged from $169.32 to $170.28.
Referenced by the price of 1 transaction in Table I.
- F5
Sale prices ranged from $170.70 to $171.63.
Referenced by the price of 1 transaction in Table I.
- F6
Sale prices ranged from $171.75 to $172.73.
Referenced by the price of 1 transaction in Table I.
- F7
Sale prices ranged from $172.83 to $173.37.
Referenced by the price of 1 transaction in Table I.
- F8
Sale prices ranged from $176.04 to $176.88.
Referenced by the price of 1 transaction in Table I.
- F9
Sale prices ranged from $177.12 to $178.00.
Referenced by the price of 1 transaction in Table I.